Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01WXU
|
|||
| Former ID |
DIB007409
|
|||
| Drug Name |
ZK-205367
|
|||
| Synonyms |
Genvascor; DE-00422; AGT (PAOD), Schering; Endothelial nitric oxide synthase (eNOS) gene therapy (PVD),Cardium; PAOD gene therapy (adenoviral-encoded eNOS), Cardium; PVD gene therapy (adenoviral-encoded eNOS), Cardium; Gene therapy (eNOS, PVD), Collateral/Berlex (Schering)
Click to Show/Hide
|
|||
| Indication | Coronary artery disease [ICD-11: BA80; ICD-10: I25.1, I25.4] | Phase 2/3 | [1] | |
| Company |
Collateral Therapeutics Inc; Bayer HealthCare Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Endothelial nitric oxide synthase gene therapy for erectile dysfunction. Curr Pharm Des. 2005;11(31):4059-67. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.